Effect of clarithromycin on septic patients

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2007, Vol 24, Issue 3

Abstract

OBJECTIVE Based on the immunomodulatory properties of clarithromycin in experimental studies, its effect on sepsis in the clinical setting was investigated. METHOD A double-blind, randomized, placebo-controlled, multicenter trial was conducted on 200 patients with sepsis from ventilator-associated pneumonia (VAP). Clarithromycin (1 g) was administered intravenously once daily for three consecutive days. The effects on survival and on the resolution of sepsis and VAP were evaluated through follow-up for 28 days. RESULTS Patients treated with placebo or clarithromycin were matched for age, sex and disease severity; the type of pathogen and susceptibility to the administered antimicrobials did not differ between the two groups. Serious adverse events were observed in 0% and 3%, respectively (Ρ=NS). The sepsis resolved in 58% and 64%, respectively (P=0.65) within a median period of 11.00 and 6.00 days (P=0.021). VAP resolved in 54% and 61%, respectively (Ρ=NS) within a median period of 11.50 and 7.00 days (P=0.006). Sepsis-attributable mortality after 16 days was 21% and 10%, respectively (P=0.049) among all patients enrolled and 54.5% and 25.0%, respectively among patients with multiple organ failure (P=0.036). Risk of death after 28 days with multiple organ failure decreased by a factor of 2.75 with administration of clarithromycin. Kaplan-Meier analysis revealed prolongation of survival for 28 days from the early signs of sepsis (P=0.021) in patients with septic shock treated with clarithromycin. CONCLUSIONS The earlier resolution of sepsis and the dramatic decrease in the risk of death in multiple organ failure observed in the patients treated with clarithromycin, signal new perspectives for the utilization of clarithromycin in (a) VAP, (b) septic shock, and (c) multiple organ failure

Authors and Affiliations

E. GIAMARELLOS-BOURBOULIS, C. ROUTSI, M. RAFTOGIANNIS, S. KOLLIAS, F. BAZIAKA, D. ZERVAKIS, T. TSAGANOS, A. ARMAGANIDIS, H. GIAMARELLOU

Keywords

Related Articles

Parasitic infections

Parasitic infections, which are most prevalent in developing countries, in recent years present a new diagnostic and therapeutic challenge to physicians of the developed countries, because of increased international trav...

Sleep apnea and type 2 diabetes mellitus

Type 2 diabetes mellitus (T2D) is a major public health concern, with high morbidity, mortality, and health-care costs. Studies have shown that subjects with T2D may also have obstructive sleep apnea (OSA). OSA is a risk...

Systematic errors in etiological epidemiological studies

Measurement error refers to deviations between the estimated and the true value of a (biological) variable, which are not caused by mistakes. In epidemiological studies, errors are classified into random and systematic a...

Τhe developmental approach to sleep disorders

Sleep disorders of childhood are quite common, but they have been studied to a lesser extent than those of adulthood. This review, which concerns only the primary sleep disorders and not sleep disorders related to other...

Download PDF file
  • EP ID EP91285
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

E. GIAMARELLOS-BOURBOULIS, C. ROUTSI, M. RAFTOGIANNIS, S. KOLLIAS, F. BAZIAKA, D. ZERVAKIS, T. TSAGANOS, A. ARMAGANIDIS, H. GIAMARELLOU (2007). Effect of clarithromycin on septic patients . Αρχεία Ελληνικής Ιατρικής, 24(3), 170-177. https://europub.co.uk/articles/-A-91285